Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial

The Lancet Oncology 2026

View at publisher
Authors: Alicia K Morgans, Kunhi Parambath Haresh, Mindaugas Jievaltas, David Olmos, Neal D Shore, Egils Vjaters, Nianzeng Xing, ATEESHA F. MOHAMED, Natasha Littleton, Shankar Srinivasan, Frank Verholen, Fred Saad
DOI: 10.1016/s1470-2045(26)00014-8
Cited by: 1
References: 23

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Pain Management and Opioid Use

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
5
Pages
614–624
Publication date
10 April 2026
Language
EN